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Background: Notch signaling is known to be activated following myocardial ischemia, but its role in
cardioprotection provided by ischemic preconditioning (IPC) and ischemic postconditioning (IPost) remains unclear.
Methods: Lentiviral vectors were constructed to overexpress or knockdown N1ICD in H9c2 cardiomyocyte and rat
heart exposed to ischemia reperfusion injury (IRI), IPC or IPost.
Results: Notch1 signaling was activated during myocardial IPC and IPost, and could enhance cell viability and
inhibit apoptosis. Furthermore, activated Notch1 signaling stabilized mitochondrial membrane potential and
reduced reactive oxygen species induced by IRI. The cardioprotection provided by activated Notch1 signaling
resembled that of IPC and IPost, which was related to Stat3 activation and regulation of apoptosis related proteins.
Furthermore, in langendorff heart perfusion model, activated Notch1 signaling restored cardiac function, decreased
lactate dehydrogenase release and limited infarct size after myocardial ischemia. Conclusions: Notch1 signaling is
activated and mediates cardioprotection provided by IPC and Ipost. Notch1 signaling may represent a potential
new pharmacologic mimic for cardioprotection of ischemic heart disease.
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Ischemic postconditioningIntroduction
It is well known that immediate restoration of cardiac
blood flow after prolonged ischemia would contradictorily
result in ischemia reperfusion injury (IRI), which would
accelerate the deterioration of cardiac function [1]. Ische-
mia preconditioning (IPC) has shown beneficial effects such
as limiting infarct size and reducing lethal arrhythmia after
IRI in many species including human being [2,3]. On
the other hand, ischemia postconditioning (IPost) indicates
brief episodes of nonlethal ischemia/reperfusion applied at
the onset of reperfusion [4]. Accumulating evidence indi-
cates that IPC and IPost activate various survival signaling
pathways to provide cardioprotection [5,6]. Therefore,
developing pharmacologic mimics such as endogenous
autacoids to provide myocardial protection have important* Correspondence: liujichun999@163.com
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reproduction in any medium, provided the orclinical significance for the treatment of ischemic heart
disease (IHD).
Notch signaling is an evolutionary conserved signaling
pathway which plays a crucial role in cell fate decision, cell
differentiation, proliferation, and apoptosis [7]. There are
four receptors (Notch1-4) and five ligands (Jagged1-2 and
Delta like 1, -3,-4) in mammals, the hairy and enhancer of
split (Hes) and hes-related (Hey) families of transcriptional
repressors have been identified as Notch classical target
genes [8]. Notch signaling has been implicated in heart
disease. Notch1 and Jagged1 levels were lower in adult
heart, but N1ICD, Jagged1 and Delta4 were accumulated
in the border zone of the infarct region at 4 days after
ischemia [9]. Quantitative RT-PCR analysis revealed that
the expression of Notch1-4, Jagged1 and Hes1 were in-
creased within the first week following myocardial infarct
[10]. Notch signaling was activated in cardiomyocytestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Notch1, Jagged1 and Hes1 were upregulated in dilated or
hypertrophic hearts [11]. In addition, Notch signaling can
stimulate immature cardiomyocyte proliferation and pro-
mote quiescent cardiomyocytes to reenter the cell cycle
[12,13]. However, whether activated Notch signaling fol-
lowing myocardial ischemia plays cardioprotective effects
during IPC and IPost remains unclear.
Therefore, in this study we investigated the role of
Notch1 signaling in cardioprotection provided by IPC and
IPost, using both cardiomyocyte and rat heart model. Our
results showed that the inhibition of Notch1 signaling via
the knockdown of N1ICD abrogated the cardioprotection
provided by IPC and IPost.
Materials and methods
Reagents and antibodies
Dulbecco’s modified Eagle’s medium (DMEM) and trypsin
were from Gibco BRL (USA). Fetal bovine serum (FBS)
was from NQBB International Biological Corporation
(Australia). Cell counting kit-8 (CCK-8) and Reactive oxy-
gen species assay kits were from Beyotime institute of
biotechnology (China). Annexin V-FITC apoptosis de-
tection kit was obtained from KeyGEN Biotech(China).
Mitochondria staining kit (JC-1) was purchased from
MultiSciences Biotech (USA). Mitochondria isolation kit
was purchased from Applygen Technologies (China). LDH
kits were purchased from Nanjing jiancheng bioengineering
institute, 2,3,5-triphenyltetrazolium chloride (TTC) was
from SolarbioTechnologies (China). Enhanced chemilumin-
escence kit was purchased from Thermo Scientific (USA).
Notch1 and Hes1 antibodies were purchased from Abcam
(USA), Flag, Bcl-xL and Bax antibodies were purchased
from Cell Signaling Technology (USA), Stat3, p-Stat3
and β-Actin antibodies were purchased from Anbo Bio-
technology Company (USA).
Cell culture
Rat cardiac H9c2 cells (ATCC Rockville, USA) were cul-
tured in DMEM supplemented with 10% FBS at 37°C in
a humidified incubator with 5% CO2. The cells were fed
every 3 days and subcultured once reaching 90% conflu-
ence. Cells were plated at an appropriate density according
to each experimental design.
Virus vector construction and infection
Rat N1ICD cDNA (Notch1:5456–7819) was generated by
PCR using forward primer: 5′-GAGGATCCCCGGGTAC
CGGTCGCCACCATGGTGCTGCTGTCCCGCAAG-3′
and reverse primer: 5′-TCATCCTTGTAGTCGCTAGCC
TTAAATGCCTCTGGAATG-3′. The amplified fragment
was subcloned into pGC-FU-EGFP-3Flag to get pGC-FU-
N1ICD-3Flag vector. Rat N1ICD-shRNAs were designed
according to Ambion with the following sequences:GCACAGTGCTGAGTACCAA (N1ICD-shRNA-1), GCC
TCTCCACCAATACCTT (N1ICD-shRNA-2), CCCACAT
TCCAGAGGCATT (N1ICD-shRNA-3), TCTGGATGCC
CGAATGCAT (N1ICD-shRNA-4) with CTCGAG as the
loop sequence. The oligonucleotide-annealed products
were subcloned into pGVC112 to get pGVC112-N1ICD-
shRNA vectors. An irrelevant TTCTCCGAACGTGTCA
CGT was used as negative control.
To generate lentiviral vectors, either 20 μg pGC-FU-
N1ICD-3Flag or pGVC112-N1ICD-shRNA was transfected
along with 15 μg pHelper 1.0 and 10 μg pHelper 2.0 into
293T cells in 10 cm plate at 80% confluence for 8 h. The
medium was replaced with fully supplemented DMEM
and the supernatants were harvested after 72 h for virus
titration, which were then stored at −80°C.
To infect H9c2 cells, multiplicity infection (MOI) of
20 lentiviral particles with 5 μg/ml polybrene were added
into the medium, 24 h later the medium was changed
and H9c2 cells were cultured for an additional 72 h.
To infect Sprague–Dawley rat, 100 μl pseudo viral
particles (1×108/ml) were injected into the tail vein, 4
weeks after infection, Sprague–Dawley rats were collected
for analysis.In vitro protocols of hypoxia/reoxygenation (H/R), IPC, IPost
For H/R, H9c2 cells were cultured in hypoxic solution in
a hypoxic incubator (95% N2-5% CO2) for 3 h, subse-
quently hypoxic solution was replaced with reoxygenation
solution, and the cells were cultured in a high oxygen
incubator (95% O2-5% CO2) for 3 h.
For IPC, H9c2 cells were cultured in hypoxic solution
in a hypoxic incubator (95% N2-5% CO2) for 10 min,
subsequently the hypoxic solution was replaced with
reoxygenation solution, and the cells were cultured in a
high oxygen incubator (95% O2-5% CO2) for 10 min.
The hypoxia-reoxygenation cycle was repeated 3 times
and followed by H/R treatment.
For IPost, at the end of the 3 h hypoxia, the hypoxic
solution was replaced with reoxygenation solution and
H9c2 cells were cultured in a high oxygen incubator for
10 min. Next the medium was changed to hypoxic solu-
tion and the cells were cultured in a hypoxic incubator
for another 10 min. The reoxygenation-hypoxia cycle was
repeated 3 times and followed by continuous culture in
reoxygenation solution in a high oxygen incubator for 3 h.Cell viability assay
H9c2 cells were seeded into a 96-well plate at 10,000
cells/well and cultured in 100 μL DMEM supplemented
with 10% FBS for 24 h, then treated as indicated. Finally,
the cell viability was detected using CCK-8 Kit (Dojindo,
Japan) according to the manufacturer’s instructions. The
absorbance was measured at 450 nm using a Microplate
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was calculated with the control cells set as 100%.
Apoptosis assay
H9c2 cells were harvested and 4×105 cells were resuspended
in 500 μl binding buffer, then incubated with 5 μl Annexin
V-FITC and 5 μl propidium iodide (PI) at room temperature
in dark for 15 min. The samples were analyzed by flow
cytometry with a BD FACSCalibur. Apoptosis ratio was
defined as the ratio between Annexin V positive/PI
negative cells and the total living cells.
Detection of intracellular reactive oxygen species (ROS)
H9c2 cells were harvested and 105 cells were incubated
with 10 μmol/L DCFH-DA at 37°C for 20 min. The DCF
fluorescence was detected by BD FACSCalibur excited
at 488 nm and the emitted fluorescence was collected
at 525 nm.
Determination of mitochondrial membrane potential (ΔΨm)
H9c2 cells were harvested and 105 cells were loaded with
JC-1 (2 μM) at 37°C, 5% CO2 for 20 min, then analyzed by
BD FACSCalibur excited at 488 nm and the emitted fluor-
escence was collected at 530 nm and 590 nm. ΔΨm was
expressed as the emitted fluorescence ratio (590/530 nm)
in percentage to the initial level, whereas 0% level was
recorded after complete mitochondrial depolarization with
carbonyl cyanide-p-trifluoromethoxyphenylhydra-zone.
Langendorff heart perfusion
Male Sprague–Dawley rats (weight 220 to 250 g) were
obtained from Jiangxi University of Traditional Chinese
Medicine (China). All animals were treated in accord-
ance with the Guide for the Care and Use of Laboratory
Animals, and approved by the Ethics Committee of the
first affiliated hospital of Nanchang University (permit
No: NDYFY-2012-YYLSD-016). The rats were anesthe-
tized with pentobarbital sodium (100 mg/kg intraperi-
toneally). Hearts were excised and retrograde perfused
via the aorta with modified Krebs-Henseleit buffer
(NaCl 118 nM, KCl 4.7 nM, MgSO4 1.2 nM, CaCl2 2.5 nM,
NaHCO3 2 nM, KH2PO4 1.2 nM, Glucose 11 nM, pH
7.35-7.45) equilibrated with 95% O2-5% CO2. Left
ventriculardeveloped pressure (LVDP), heart rate (HR)
and intraventricular pressure (±dP/dt) were measured
by Powerlab pressure transducer with a balloon inserted
into the left ventricle. In the Control, Mock1 and Mock2
groups, hearts were buffer perfused without ischemia.
In ischemia/reperfusion (I/R) group, hearts were first
equilibrated for 20 min followed by 30 min of stop-flow
ischemia and 120 min of reperfusion. In IPC group,
after 3 cycles of 5 min of ischemia and 5 min of reperfu-
sion, hearts were subjected to 30 min of no-flow ische-
mia, followed by 120 min of reperfusion. In IPost group,hearts were subjected to 30 min of stop-flow ischemia,
before 120 min of reperfusion, 3 cycles of 10 s of ische-
mia and 10 s of reperfusion were applied.
Lactate dehydrogenase (LDH) assay
Coronary effluent was collected at 1 min before ischemia,
1 min after ischemia and 1 min after reperfusion to deter-
mine LDH activity by using LDH kits according to the
manufacturer’s instructions. LDH activity was expressed
as international units per liter (IU/L).
Assessment of infarct size
The heart was frozen at −20°C for 30 min, then sectioned
from apex to base into five to six 1 mm sections. The sec-
tions were incubated in 1%TTC at 37°C for 30 min and
fixed in 10% formaldehyde for 24 h. The normal myocar-
dium was stained brick red with TTC while the infarcted
portion was not stained and appeared pale white. The
infarct area-IA (white) and the area at risk-AAR (red
and white) from each section were measured using Image
Pro 6.0 Plus software. For each section, infarct size was
expressed as the percentage of IA/AAR.
Western blot analysis
At different time points of the experiemtns, cells or the
hearts were harvested immediately and lysed in cell lysis
buffer (Beyotime Institute of Biotechnology, China) at 4°C.
Protein samples were separated by 8-10% SDS-PAGE,
then transferred to nitrocellulose membranes (Millipore)
and blocked in 10% nonfat milk in TBST (150 mM NaCl,
50 mM Tris pH 7.5, 0.1% Tween-20). Membranes were
incubated with primary antibodies overnight at 4°C, fol-
lowed by incubation with secondary antibodies at room
temperature for 1 h. The fluorescent signals were de-
tected using enhanced chemiluminescence by ImageQuant
LAS4000 (GE, USA). Relative protein levels were nor-
malized to that of β-actin.
Statistical analysis
Data were analyzed using the SPSS version 12 statistical
analysis package (SPSS Inc., Chicago, IL, USA). Exam-
ined data were assessed using ANOVA. In each test, the
data were expressed as the mean±SD, and P<0.05 was
accepted as statistically significant.
Results
Identification of LV-N1ICD and LV-N1ICD-shRNA vectors
In 293T cells transfected with pGC-FU-N1ICD-3Flag
vector, we observed ectopic expression of N1ICD
(Figure 1A). Furthermore, in H9c2 cells and rats infected
with lentiviral vector LV-N1ICD, we observed ectopic
expression of N1ICD in the cells or hearts (Figure 1B-C).
In contrast, in 293T cells cotransfected with pGC-FU-
N1ICD-3Flag vector and N1ICD-shRNA-1 to 4, we
Figure 1 Identification of LV-N1ICD and LV-N1ICD-shRNA vectors. A, Western blots showing the expression of Flag tagged N1ICD in 293T
cells as indicated. B, Western blots showing the expression of Flag tagged N1ICD in H9c2 cells as indicated. C, Western blots showing the
expression of Flag tagged N1ICD in the hearts of the rats as indicated, D, Western blots showing the expression of Flag tagged N1ICD in 293T
cells transfected with pGC-FU-N1ICD-3Flag along with negative control pGVC112-shRNA (Mock), pGVC112-N1ICD-shRNA-1 (N1ICD-shRNA-1),
pGVC112-N1ICD-shRNA-2 (N1ICD-shRNA-2), pGVC112-N1ICD-shRNA-3 (N1ICD-shRNA-3), or pGVC112-N1ICD-shRNA-4 (N1ICD-shRNA-4). E, Western
blots showing the expression of endogenous N1ICD in H9c2 cells infected by lentivirus as indicated, F, Western blots showing the expression of
endogenous N1ICD in the hearts of the rats infected by lentivirus as indicated. β-actin was loading control.
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in cells transfected with N1ICD-shRNA-3 (Figure 1D).
Thus we constructed N1ICD lentiviral interference vec-
tor (LV-N1ICD-shRNA) using the sequence of N1ICD-
shRNA-3 and infected H9c2 cells or rats, we observed
efficient knockdown of endogenous N1ICD expression in
the cells or hearts (Figure 1E-F). Taken together, these
results suggest that LV-N1ICD and LV-N1ICD-shRNA
vectors are efficient to overexpress and knockdown
N1ICD in vitro and in vivo, respectively.
Notch1 signaling is activated during myocardial IPC and IPost
Western blot analysis showed that N1ICD and Hes1 ex-
pression in H9c2 cells was increased slightly during H/R
but increased significantly during IPC and IPost (Figure 2A
and 2B). In addition, Hes1 level was increased in H9c2
cells treated by LV-N1ICD infection and H/R, but de-
creased in H9c2 cells treated by LV-N1ICD-shRNAinfection and IPC or IPost (Figure 2B), confirming that
Hes1 is a target gene of Notch signaling. These data
suggest that Notch1 signaling is activated during myo-
cardial IPC and IPost.
Myocardial IRI is mitigated by activated Notch1 signaling
To investigate the role of Notch1 signaling in myocardial
protection, the cell viability was detected after H9c2 cells
were exposed to H/R, IPC or IPost. Ectopic expression
of N1ICD in H9c2 cells exposed to H/R enhanced myo-
cardial cell viability, however, the viability of myocardial
cells exposed to IPC and IPost was decreased when N1ICD
was knockdown by LV-N1ICD-shRNA (Figure 3A).
Next, we observed the effect of Notch1 signaling on
cell apoptosis after myocardial ischemia. The results
demonstrated that the apoptosis of cardiomyocyte in
H/R was greatly reduced after N1ICD overexpression,
but it was substantially increased upon N1ICD knockdown
Figure 2 Notch1 signaling is activated in H9c2 cells exposed to IPC and IPost. A, N1ICD level was upregulated in IPC and IPost. B, Hes1 level
was regulated by H/R, IPC and IPost with or without LV-N1ICD/LV-N1ICD-shRNA infection. Data were presented as mean±SD, n=3. Mock1 indicated
cells infected with empty vector, Mock2 indicated cells infected with vector containing nonspecfic sequences.▲P>0.05, *P<0.05, **P<0.01.
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data suggest that Notch1 signaling mitigates myocardial IRI
by promoting the viability and inhibiting the apoptosis
of cardiomyocytes.
Notch1 signaling inhibits the mitochondrial permeability
transition pore (mPTP) opening in cardiomyocytes
To observe the effect of Notch1 on mPTP during IRI,
we detected ΔΨm by JC-1 staining. We observed that
LV-N1ICD infection during H/R prevented mitochondrial
from serious depolarization, while LV-N1ICD-shRNA
infection during IPC and IPost exerted opposite effect,
ΔΨm became extremely low that showed no significant
difference compared with H/R (Figure 4A). These data
indicate that activated Notch1 suppresses the opening
of mPTP.
Next we measured intracellular ROS in H9c2 cells
and found that ectopic expression of N1ICD mitigated
ROS accumulation caused by H/R, but knockdown of
N1ICD promoted ROS accumulation during IPC and
IPost (Figure 4B). These data suggest that Notch1 sig-
naling inhibits mPTP opening in cardiomyocytes via the
reduction of intracellular ROS accumulation.
Notch1 signaling activates Stat3 and regulates apoptosis
related proteins in cardiomyocytes
To explore the molecular mechanism underlying
Notch1 mediated cardioprotection, we detected Stat3phosphorylation in H9c2 cells. The phosphorylation of
Stat3 was elevated not only upon IPC or IPC treatment,
but also in N1ICD overexpressed H9c2 cells under H/R.
However, the elevated phosphorylation of Stat3 was im-
mediately reversed upon N1ICD knockdown during IPC
or IPost (Figure 5A).
Furthermore, we detected anti-apoptosis protein Bcl-xl
and pro-apoptosis protein Bax in H9c2 cells. The results
showed that ectopic expression of N1ICD increased Bcl-xl
expression and decreased Bax expression under H/R, but
N1ICD knockdown during IPC or IPost decreased Bcl-xl
level and increased Bax level (Figure 5B). Collectively,
these data provide evidence that cardioprotection effects
of Notch1 signaling are mediated by Stat3 activation and
regulation of apoptosis related proteins.
Notch1 signaling contributes to the restoration of cardiac
function in post-ischemia rats
After langendorff-perfused isolated heart models were
established, we measured the parameters of cardiac func-
tion. The results showed that the recovery of cardiac
function in I/R was strengthened by ectopic expression
of N1ICD, as evidenced by the increases of HR, LVDP
and ±dp/dt. However, upon N1ICD knockdown, the recov-
ery effects of IPC or IPost on cardiac function disappeared
because the values of HR, LVDP and ±dp/dt were de-
creased to basic level of I/R (Figure 6). In addition, we
found that N1ICD and Hes1 expression in myocardium
Figure 3 Myocardial IRI is mitigated by activated Notch1 signaling. A, Myocardial cell viability was enhanced by ectopic expression of
N1ICD and inhibited by knockdown of N1ICD. B, IRI induced apoptosis was inhibited by ectopic expression of N1ICD but promoted by
knockdown of N1ICD. The apoptosis of H9c2 cells was detected based on Annexin V/FITC and PI staining and flow cytometry. Data were
presented as mean±SD, n=3. Mock1 indicated cells infected with empty vector, Mock2 indicated cells infected with vector containing
nonspecfic sequences.▲P>0.05, *P<0.05, **P<0.01.
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by LV-N1ICD or LV-N1ICD-shRNA (Figure 7A and 7B).
These data suggest that Notch1 signaling is activated dur-
ing IPC and IPost in langendorff-perfused isolated heart
models, and Notch1 signaling contributes to the restor-
ation of cardiac function after ischemia.
Notch1 signaling reduces myocardial necrosis after
ischemia in rats
Global ischemia for 30 min followed by 120 min of re-
perfusion markedly increased the release of LDH. Three
episodes of IPC and IPost significantly reduced I/R induced
increase in the release of LDH. Moreover, IPC caused de-
crease in the release of LDH was significantly restored in
LV-N1ICD-shRNA infected rat hearts. However, ectopic
expression of N1ICD significantly attenuated the increase
in the release of LDH (Figure 8A). Similarly, the increased
infarct size induced by I/R was limited by ectopic expres-
sion of N1ICD and by IPC or IPost treatment. However,
N1ICD knockdown led to significant increase in infarct size
during IPC and IPost (Figure 8B and 8C). These data indi-
cate that Notch1 signaling can reduce myocardial necrosisafter ischemia. Furthermore, the phosphorylation of Stat3
was enhanced by IPC and IPost treatment, or by N1ICD
overexpressed in I/R. However, the elevated phosphoryl-
ation of Stat3 was obviously decreased upon N1ICD knock-
down during IPC or IPost (Figure 7C).
Discussion
The activation of Notch signaling following tissue injury
has been documented in various tissues [14,15]. In this
study we observed that the expression of N1ICD and
Hes1 was greatly increased in H9c2 cells exposed to IPC
and IPost, but not to H/R, suggesting that endogenous
cardioprotection phenomenon is associated with the ac-
tivation of Notch signaling. These data are consistent
with recent findings that Notch1 signaling is implicated
in myocardial protection mediated by IPC [16]. In addition,
we found that IR-induced necrosis and apoptosis in H9c2
cardiomyocytes were mitigated by activated Notch1 signal-
ing. Furthermore, in langendorff isolated heart perfusion
model, we demonstrated that activation of Notch1 not
only reduced the release of LDH and limited the infarct
size, but also improved cardiac function after ischemia.
Figure 4 Notch1 signaling inhibits mitochondrial mPTP opening in H9c2 cells exposed to ischemia. A, Measurement of ΔΨm in
different groups of H9c2 cells. B, Measurement of ROS accumulation in different groups of H9c2 cells. Data were presented as mean±SD,
n=3. Mock1 indicated cells infected with empty vector, Mock2 indicated cells infected with vector containing nonspecfic sequences.
▲P>0.05, *P<0.05, **P<0.01.
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endogenous cardioprotcetive factor to play an important
role in the protection of ischemic myocardium during
IPC and IPost.
mPTP is a non-specific channel in the mitochondrial
inner membrane. Experimental evidences suggest that
irreversible opening of mPTP is a critical mediator of le-
thal IRI, but IPC and IPost can direct or indirectly in-
hibit the opening of mPTP by various survival signaling
pathway [17]. In the present study, we monitored the
mPTP opening by ΔΨm and found that activated Notch1
alleviated the loss of ΔΨm induced by H/R, while knock-
down of N1ICD during IPC and IPost exacerbated the loss
of ΔΨm. These results indicate that the mPTP opening
induced by H/R is partly inhibited by Notch1 signaling.
Furthermore, we found that Notch1 decreased the pro-
duction of intracellular ROS during H/R, in agreement
with previous results that Notch1 signaling protected
hepatocytes from IRI by repressing ROS [18].
Cardiomyocyte apoptosis is a complex molecular event
controlled by a variety of apoptosis related proteins such
as Bcl-2 family. The Bcl-2 family consists of pro-apoptoticfactors such as Bad, Bid and Bax, and anti-apoptotic fac-
tors such as Bcl-2 and Bcl-xl. Bax can directly induce
mPTP opening, leading to the release of cytochrome C
and the activation of apoptotic signaling pathways [19].
Notch signaling could upregulate Bcl-2 and Bcl-xl ex-
pression and downregulate Bax and Bim expression,
thereby inhibiting apoptosis [20]. In current study, the
upregulation of Bax and downregulation of Bcl-xl induced
by H/R were reversed by activated Notch1 signaling, but
were promoted upon knockdown of N1ICD during IPC
and IPost. Therefore, we propose that Notch1 inhibits
myocardial apoptosis induced by IRI through regulating
the expression of Bcl-2 family members.
Several studies have shown that the activation of Stat3
in IR not only reduces cardiomyocyte death, but also
attenuates adverse cardiac remodeling [21,22]. Further-
more, myocardial IPC and IPost can enhance Stat3
phosphorylation and activity, which contribute to the
cardioprotection provided by IPC and IPost [23,24]. In
the current study, Stat3 phosphorylation was upregulated
during endogenous cardioprotection mediated by IPC and
IPost, but was inhibited upon the knockdown of N1ICD.
Figure 5 Notch1 signaling regulates Stat3 phosphorylation and the expression of Bcl-xl and Bax in H9c2 cells exposed to ischemia.
A, The phosphorylation of Stat3 in different groups of H9c2 cells. B, The expression of Bcl-xl and Bax in different groups of H9c2 cells. β-actin
was loading control. Data were presented as mean±SD, n=3. Mock1 indicated cells infected with empty vector, Mock2 indicated cells
infected with vector containing nonspecfic sequences. ▲P>0.05, *P<0.05, **P<0.01.
Figure 6 Notch1 signaling improves cardiac function in isolated rat hearts. A-D, Measurement of heart rate (HR), left ventricular developed
pressure (LVDP) and maximal (dP/dtmax) and minimal (dP/dtmin) value of the first derivative of left ventricular pressure. Data were shown as the
percentage of the values recorded at 1 min before ischemia. Data were presented as mean±SD, n=6. a: I/R+N1ICD vs I/R; P<0.05; b: IPC vs I/R,
P<0.05; c: IPC vs IPC+shRNA, P<0.05; d: IPost vs I/R, P<0.05; e: IPost vs IPost+shRNA, P<0.05.
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Figure 7 The activation of Notch signaling in langendorff-perfused isolated heart. A, N1ICD level was upregulated in IPC and IPost. B, Hes1
level was regulated by I/R, IPC and IPost with or without LV-N1ICD/LV-N1ICD-shRNA infection. C, The phosphorylation of Stat3 in different groups
of myocardium. Data were presented as mean ± SD, n=3. Mock1 indicated the hearts infected with empty vector, Mock2 indicated the hearts
infected with vector containing nonspecfic sequences. ▲P>0.05, *P<0.05, **P<0.01.
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cardium from IRI by enhancing Stat3 phosphorylation
and activation.
Conclusions
In summary, in this study we provide a series of evi-
dence that Notch1 signaling is activated and mediatesFigure 8 Notch1 signaling inhibits LDH release and reduces infar
B, infarct size in each group. C, TTC staining of cardiac slices in each
the hearts infected with empty vector, Mock2 indicated the hearts in
*P<0.05, **P<0.01.cardioprotection provided by IPC and IPost. Notch1 sig-
naling exerts endogenous cardioprotection to mitigate
IRI through the inhibition of mPTP opening, the regula-
tion of Bcl-2 family member expression, and the activa-
tion of Stat3. Our results suggest that Notch1 signaling
may represent a potential new pharmacologic mimic for
cardioprotection of IHD.ct size in isolated rat hearts. A, LDH release in each group.
group. Data were presented as mean±SD, n=6. Mock1 indicated
fected with vector containing nonspecfic sequences. ▲P>0.05,
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